A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C. (Q43982225)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

J M Wall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

E Linardatos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

S Benvenga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

P Hauser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

RC16-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15505982%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03347491

4 January 2020

exact match

0 references

cites work

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Hepatitis C, interferon alfa, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Side effects of therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Interferons, serotonin and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

The role of thyroid hormones in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Cytokines in endocrinology: their roles in health and in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Cytokines and depression: an analogic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Cytokines, stress and depressive illness: brain‐immune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347491

Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism

21 January 2018

1 reference

12 December 2020

Increased production of thyroxine and inappropriately elevated serum thyrotropin in levels in endogenous depression

1 reference

12 December 2020

Sertraline treatment of interferon-alfa-induced depressive disorder

1 reference

12 December 2020

Five cases of interferon-alpha-induced depression treated with antidepressant therapy

1 reference

12 December 2020

Reversible inhibition by interferons alpha and beta of 125I incorporation and thyroid hormone release by human thyroid follicles in vitro

1 reference

12 December 2020

The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C

1 reference

12 December 2020

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

12 December 2020

Neuroendocrine-immune interactions.

1 reference

12 December 2020

Mood and cognitive side effects of interferon-alpha therapy

1 reference

12 December 2020

Expression of endocrine autoantibodies in chronic hepatitis C, before and after interferon-alpha therapy

1 reference

12 December 2020

Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.

1 reference

12 December 2020